David R.w. Jayne - 18 May 2022 Form 4/A - Amendment Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Director
Signature: /s/ David R.W. Jayne, M.D.
Issuer symbol: AUPH
Transactions as of: 18 May 2022
Net transactions value: +$36,200
Form type: 4/A - Amendment
Filing time: 11 Jul 2022, 06:16:31 UTC
Date Of Original Report: 20 May 2022
Previous filing: 16 Jun 2021
Next filing: 23 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Options Exercise	$36,200	+10,000	+33%	$3.62	40,000	18 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUPH	Stock Option (right to buy)	Options Exercise	$0	-10,000	-100%	$0.000000^*	0	18 May 2022	Common Stock	10,000	$3.62	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
F2	The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date.

Remarks:

This amendment is filed to correct the inadvertent omission of the option exercise transaction from the Reporting Person's Form 4 filed on May 20, 2022.